Home > Healthcare > Medical Devices > Diagnostic Devices > gastrointestinal diagnostics market
Get a free sample of Gastrointestinal Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Gastrointestinal Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market is experiencing significant growth due to rising global prevalence of GI disorders like colorectal cancer and IBD, fuelled by factors such as aging populations and lifestyle changes. Key players, including diagnostic labs, healthcare providers, and medical device manufacturers, drive innovation with technologies like molecular diagnostics and AI-enabled tools, expanding diagnostic capabilities. Initiatives in preventive medicine and personalized healthcare are reshaping the landscape, emphasizing early detection and tailored treatment approaches. As demand for accurate GI diagnostics continues to escalate, market expansion, collaboration, and investment in advanced solutions are key strategies for industry players.
Prominent players operating in the gastrointestinal diagnostics industry include:
The culture and sensitivity testing technology segment in the gastrointestinal diagnostics industry accounted for 33.6% share in 2023 and is projected grow at significant rate from 2024 to 2032, due to growing need for accurate and timely identification of causative agents to guide appropriate treatment.
The endoscopy test type segment in the gastrointestinal diagnostics industry recorded USD 1.7 billion in 2023, as it provides direct visualization of the gastrointestinal (GI) tract, allowing for accurate and precise diagnosis of various GI conditions such as ulcers, polyps, inflammation, and tumors.
Gastrointestinal diagnostics industry size was worth USD 4.8 billion in 2023 and is projected to expand at 4.6% CAGR from 2024 to 2032, due to the increasing prevalence of GI disorders, rising adoption of non-invasive diagnostic techniques, and growing healthcare expenditure.
North America gastrointestinal diagnostics market recorded USD 1.9 billion in revenue in 2023 and is projected to grow at 4.4% CAGR between 2024 and 2032, led by the increasing burden of gastrointestinal diseases, like colorectal cancer, inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and infectious gastrointestinal illnesses.